{"id":572,"date":"2011-09-01T02:37:09","date_gmt":"2011-09-01T06:37:09","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=572"},"modified":"2011-09-01T02:37:09","modified_gmt":"2011-09-01T06:37:09","slug":"crude-oil-divergence-continues","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/","title":{"rendered":"Crude oil divergence continues"},"content":{"rendered":"

The spread between Brent Crude and Nymex WTI Light Crude remains at $24\/barrel. Brent is rallying to test the declining trendline, but retreat to medium-term support at $105 is likely. Resolution of the conflict in Libya should take some of the supply pressure off European refineries, easing Brent prices.<\/p>\n

\"Brent<\/p>\n

* Target calculation: 105 – ( 120 – 105 ) = 90<\/span><\/p>\n

We then have to wait and see what Chairman Ben pulls out of his hat at the September 21st FOMC meeting. Further quantitative easing would cause an upward spike in commodity prices, including crude.<\/p>\n","protected":false},"excerpt":{"rendered":"

The spread between Brent Crude and Nymex WTI Light Crude remains at $24\/barrel. Brent is rallying to test the declining trendline, but retreat to medium-term support at $105 is likely. Resolution of the conflict in Libya should take some of the supply pressure off European refineries, easing Brent prices. * Target calculation: 105 – ( … <\/p>\n

Continue reading “Crude oil divergence continues”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8],"tags":[495,2100,2105,2525,2831,3712],"class_list":["post-572","post","type-post","status-publish","format-standard","hentry","category-gold-commodities","tag-brent-crude","tag-libya","tag-light-crude","tag-nymex","tag-quantitative-easing","tag-wti"],"yoast_head":"\nCrude oil divergence continues - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crude oil divergence continues - the patient investor\" \/>\n<meta property=\"og:description\" content=\"The spread between Brent Crude and Nymex WTI Light Crude remains at $24\/barrel. Brent is rallying to test the declining trendline, but retreat to medium-term support at $105 is likely. Resolution of the conflict in Libya should take some of the supply pressure off European refineries, easing Brent prices. * Target calculation: 105 – ( … Continue reading "Crude oil divergence continues"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2011-09-01T06:37:09+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2011\/2011-09-01-crude.png\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"Crude oil divergence continues\",\"datePublished\":\"2011-09-01T06:37:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/\"},\"wordCount\":90,\"commentCount\":2,\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2011\\\/2011-09-01-crude.png\",\"keywords\":[\"Brent crude\",\"Libya\",\"light crude\",\"Nymex\",\"quantitative easing\",\"WTI\"],\"articleSection\":[\"Gold & Commodities\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/\",\"name\":\"Crude oil divergence continues - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2011\\\/2011-09-01-crude.png\",\"datePublished\":\"2011-09-01T06:37:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2011\\\/2011-09-01-crude.png\",\"contentUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2011\\\/2011-09-01-crude.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2011\\\/09\\\/01\\\/crude-oil-divergence-continues\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crude oil divergence continues\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/author\\\/colin58s\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crude oil divergence continues - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Crude oil divergence continues - the patient investor","og_description":"The spread between Brent Crude and Nymex WTI Light Crude remains at $24\/barrel. Brent is rallying to test the declining trendline, but retreat to medium-term support at $105 is likely. Resolution of the conflict in Libya should take some of the supply pressure off European refineries, easing Brent prices. * Target calculation: 105 – ( … Continue reading \"Crude oil divergence continues\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2011-09-01T06:37:09+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2011\/2011-09-01-crude.png","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"Crude oil divergence continues","datePublished":"2011-09-01T06:37:09+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/"},"wordCount":90,"commentCount":2,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2011\/2011-09-01-crude.png","keywords":["Brent crude","Libya","light crude","Nymex","quantitative easing","WTI"],"articleSection":["Gold & Commodities"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/","name":"Crude oil divergence continues - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2011\/2011-09-01-crude.png","datePublished":"2011-09-01T06:37:09+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2011\/2011-09-01-crude.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2011\/2011-09-01-crude.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/01\/crude-oil-divergence-continues\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Crude oil divergence continues"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-9e","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":795,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/14\/crude\/","url_meta":{"origin":572,"position":0},"title":"Crude","author":"ColinTwiggs","date":"September 14, 2011","format":false,"excerpt":"The strengthening dollar caused crude prices to soften, with Brent crude headed for another test of support at $104\/$105 per barrel. Failure of support would warn of a down-swing to $90, but breakout above the descending trendline is equally likely and would suggest a new primary advance. * Target calculation:\u2026","rel":"","context":"In "Gold & Commodities"","block_context":{"text":"Gold & Commodities","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/gold-commodities\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":312,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/08\/18\/crude-divergence-widens\/","url_meta":{"origin":572,"position":1},"title":"Crude divergence widens","author":"ColinTwiggs","date":"August 18, 2011","format":false,"excerpt":"The divergence between Brent crude and WTI Light crude has widened to more than $20\/barrel. WTI is clearly in a primary down-trend, but there is stubborn support for Brent at $104\/105 per barrel. Resolution of the conflict in Libya and Nigerian supply fears would see Brent prices soften to within\u2026","rel":"","context":"In "Gold & Commodities"","block_context":{"text":"Gold & Commodities","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/gold-commodities\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":435,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/08\/24\/brent-crude-ignores-good-news\/","url_meta":{"origin":572,"position":2},"title":"Brent Crude ignores good news","author":"ColinTwiggs","date":"August 24, 2011","format":false,"excerpt":"Brent crude is stubbornly holding above support at $104\/$105 per barrel despite the promise of an early resolution to the conflict in Libya. Even WTI Light crude [lime] recovered slightly after improved manufacturing orders in the US. But the primary trend is down and failure of support at $104 would\u2026","rel":"","context":"In "Gold & Commodities"","block_context":{"text":"Gold & Commodities","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/gold-commodities\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":925,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/09\/22\/brent-nymex-wti-crude\/","url_meta":{"origin":572,"position":3},"title":"Brent Nymex WTI Crude","author":"ColinTwiggs","date":"September 22, 2011","format":false,"excerpt":"Brent crude respected its declining trendline and is likely to re-test support at $104. Failure would warn of a correction to the long-term, rising trendline at 95*. * Target calculation: 105 - ( 115 - 105 ) = 95","rel":"","context":"In "Gold & Commodities"","block_context":{"text":"Gold & Commodities","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/gold-commodities\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":4312,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/05\/09\/crude-oil-falls\/","url_meta":{"origin":572,"position":4},"title":"Crude oil falls","author":"Colin Twiggs","date":"May 9, 2012","format":false,"excerpt":"Both Brent Crude and Nymex Light Crude are falling, with signs that the global economy is slowing and that tensions with Iran are easing. Brent is close to the 61.8% Fibonacci retracement level and a fall below $110\/barrel would test primary support at $100. Reversal of 63-day Twiggs Momentum below\u2026","rel":"","context":"In "Gold & Commodities"","block_context":{"text":"Gold & Commodities","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/gold-commodities\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":135,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/08\/09\/brent-crude-recovers-to-105barrel\/","url_meta":{"origin":572,"position":5},"title":"Brent Crude tests $105\/barrel","author":"ColinTwiggs","date":"August 9, 2011","format":false,"excerpt":"Today's bounce on world markets caused a rally of Brent Crude on the hourly chart, testing the former primary support level at $105\/barrel. Institutional buying of stocks does not change the fundamentals: high crude oil prices will cause a double-dip recession. No action by the Fed can change this. *\u2026","rel":"","context":"In "Gold & Commodities"","block_context":{"text":"Gold & Commodities","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/gold-commodities\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=572"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/572\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}